Bharat Parenterals Ltd
Bharat Parenterals Ltd (BPLPHARMA) last traded at ₹1,485, a market capitalisation of ₹1,023 crore. Over the past 52 weeks the stock has ranged between ₹880 and ₹1,619. Bharat Parenterals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹93.74 crore and net profit of ₹-3.56 crore. Bharat Parenterals Ltd’s annual general meeting is scheduled for 19 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Bharat Parenterals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Bharat Parenterals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹93.74 cr, down 19.2% from ₹116 cr a year earlier. Net profit was ₹-3.56 cr, down 309.2% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 71.63 | 72.26 | 104 | 116 | 64.62 | 65.19 | 99.62 | 93.74 |
| Expenses | 79.29 | 68.62 | 102 | 102 | 63.79 | 63.45 | 100 | 85.21 |
| Operating profit | -7.66 | 3.64 | 2.23 | 13.78 | 0.83 | 1.74 | -0.52 | 8.53 |
| OPM % | -10.69% | 5.04% | 2.14% | 11.88% | 1.28% | 2.67% | -0.52% | 9.10% |
| Other income | 4.21 | 2.94 | 1.93 | 1.06 | 3.53 | 1.33 | 3.63 | 1.11 |
| Interest | 2.91 | 3.33 | 3.94 | 3.69 | 3.11 | 2.9 | 2.85 | 2.45 |
| Depreciation | 9.01 | 8.76 | 8.52 | 8.6 | 8.56 | 8.46 | 8.63 | 8.69 |
| Profit before tax | -15.37 | -5.51 | -8.3 | 2.55 | -7.31 | -8.29 | -8.37 | -1.5 |
| Tax % | 13.92% | 43.01% | 13.61% | 133.73% | 17.65% | 16.77% | -2.51% | 138.00% |
| Net profit | -17.51 | -7.88 | -9.44 | -0.87 | -8.6 | -9.67 | -8.16 | -3.56 |
| EPS (₹) | -11.50 | -2.42 | -6.86 | 11.94 | -10.49 | -6.37 | -6.96 | 1.47 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Bharat Parenterals Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 205 | 212 | 218 | 261 | 340 | 345 | 323 |
| Operating profit | 25 | 29 | 20 | 27 | 4 | 16 | 11 |
| OPM % | 12% | 14% | 9% | 10% | 1.1% | 4.6% | 3.3% |
| Net profit | 20 | 21 | 16 | 11 | -44 | -27 | -30 |
| EPS (₹) | 35.59 | 36.45 | 28.47 | 24.95 | -18.33 | -11.88 | -22.35 |
TTM is the trailing twelve months to the most recent quarter.
Bharat Parenterals Ltd growth and returns
- 10 Years
- 11%
- 5 Years
- 11%
- 3 Years
- 17%
- TTM
- -11%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -172%
- 10 Years
- %
- 5 Years
- 31%
- 3 Years
- 38%
- 1 Year
- 5%
- 10 Years
- 7%
- 5 Years
- 3%
- 3 Years
- -1%
- Last Year
- -3%
Bharat Parenterals Ltd shareholding pattern
Promoters held 67.20% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.11% and DIIs 1.38%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 65.35% | 67.20% | 67.20% | 67.19% | 67.19% | 67.19% | 67.17% | 67.20% |
| FIIs | 0.08% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| DIIs | 0.57% | 0.54% | 0.54% | 0.54% | 0.54% | 0.54% | 1.07% | 1.38% |
| Public | 33.98% | 32.16% | 32.15% | 32.16% | 32.16% | 32.17% | 31.65% | 31.31% |
| No. of shareholders | 2,748 | 3,116 | 3,177 | 3,231 | 3,205 | 3,172 | 3,095 | 3,059 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Bharat Parenterals Ltd’s AGM?
Bharat Parenterals Ltd’s annual general meeting is scheduled for 19 Sept 2026.
- AGM33rd Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Bharat Parenterals Ltd corporate filings
- Intimation for publication of Pre-Newspaper Advertisement of the 33rd Annual General Meeting of the Company.Company Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has issued a formal intimation regarding the publication of a…
Read the full analysis - Intimation regarding permission to trade and Admission of Equity Shares to dealing on the National Stock Exchange of India Limited.Company Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has received formal intimation regarding the permission to trade…
Read the full analysis - Please find the enclosed newspaper notice to the physical Shareholders informing them about the special window open for re-lodging the transfer deed.Company Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has published a newspaper notice to inform physical shareholders…
Read the full analysis - Press release on Update on Expansion and Enhancement of the facility of Varenyam Biolifesciences Pvt Ltd, a Wholly Owned Subsidiary Company of Bharat Parenterals LimitedCompany Updatelow impact
Cruxal's analysis: Bharat Parenterals Limited has issued a press release regarding the expansion and…
Read the full analysis - Intimation of an analyst and investor Meet under Regulation 30 of SEBI (LODR), Regulations, 2015.Company Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has issued an intimation regarding an upcoming analyst and…
Read the full analysis - Copy of newspaper advertisement for the Unaudited Financial Results for the Quarter ended on June 30, 2026.Company Updatemedium impact
Cruxal's analysis: Bharat Parenterals Limited has released its unaudited financial results for the quarter…
Read the full analysis - Investor Presentation for the Quarter ended on June 30, 2026Company Updatehigh impact
Cruxal's analysis: Bharat Parenterals Limited reported consolidated Q1 FY27 revenue of 93.7 crore, a 19.2%…
Read the full analysis - Re-appointment of Mr. Hemang Shah as Executive Director of the Company, Subject to approval of Shareholders in enuing AGM.Company Updatelow impact
Cruxal's analysis: Bharat Parenterals Limited has formally announced the re-appointment of Mr. Hemang Shah…
Read the full analysis - Outcome of Board Meeting held on August 05, 2026Board Meetingmedium impact
Cruxal's analysis: Bharat Parenterals Limited reported Q1 FY27 consolidated revenue of 93.7 crore, a 19%…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Bharat Parenterals Ltd
Cruxal reads every Bharat Parenterals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.